Shining molecules distinguish between proteins in the brain

December 21, 2017, Linköping University
Brain tissue with Alzheimer’s pathology, stained with one of the new tau-specific molecules (orange) and one of the molecules previously developed by the group at LiU (blue). The image has been taken in a fluorescence microscope. Credit: Peter R Nilsson

Small shining molecules developed by scientists at Linköping University in Sweden can be designed to distinguish between plaque of different proteins in the brain. They may pave the way for better diagnosis of neurodegenerative diseases, such as Alzheimer's disease, in which plaque forms from the amyloid beta or tau proteins.

Researchers at Linköping University, LiU, have discovered that small changes in the structure of known tracer can enable them to recognise either beta or tau. These small molecules, which have previously been developed by the researchers, bind to a specific target protein. When the molecules are illuminated, they emit a signal in the form of light at a different wavelength.

"This opens the possibility of developing more advanced diagnostic tools for diseases in which amyloid beta and tau are involved," says Peter Nilsson, professor at the Department of Physics, Chemistry and Biology. He has led the study, which has now been presented in the scientific journal Chemistry – A European Journal.

In several diseases of the brain, long fibres of protein form, and eventually become tangled to form dense bodies known as "plaque" or "aggregates." Alzheimer's disease, which causes dementia, is one well-known example, in which the plaque usually consists of faulty variants of two proteins: amyloid beta and tau. But deposits of the tau protein in the brain are also seen in a group of less common conditions known as "tauopathies."

In recent years, several cases of brain damage in relatively young people with a professional sporting career have been widely written about. Chronic traumatic encephalopathy (CTE) can occur in individuals who have received blows to the head on repeated occasions, such as may occur in contact sports such as boxing, ice hockey and American football. Another group at risk is professional soldiers. The only way currently available to reach a firm diagnosis is during an autopsy. Thus, there is an urgent need for diagnostic tools that can be used to investigate living people, and that can distinguish between deposits of amyloid beta and tau in the brain.

What makes these molecules unique is that they have flexible backbones and adapt to the structure of the protein to which they are bound. When the molecule changes its configuration, the colour of the light that it emits changes. The researchers started with a tracer molecule that only binds to and recognises aggregates of amyloid beta. They adapted this molecule to become more similar to molecules that had been developed by other researcher groups and that bind to tau. They made two variants, and it turned out that one of the molecules binds very tightly and exclusively to tau, while the other variant was completely unsuitable.

"We see that extremely small changes, just moving a couple of atoms, can cause the tracer molecule to bind preferentially to another type of aggregate. This means that we can tailor molecules to recognise different aggregates, based on which protein is present," says Peter Nilsson.

The researchers now plan to further develop the tracer molecules by labeling them with radioisotopes, used during positron emission tomography (PET). One huge advantage of PET investigations is that they can be carried out on living people.

"If we can develop more advanced diagnostic tools that can distinguish between and tau, it would be possible to determine which aggregate forms first and how the aggregates interact. It would also be possible to investigate whether different forms of treatment are effective against one type of aggregate without affecting the other," says Peter Nilsson.

Explore further: By modeling biological molecules over longer timescales, a new algorithm can help better understand diseases

More information: Hamid Shirani et al. Synthesis of Thiophene-Based Optical Ligands That Selectively Detect Tau Pathology in Alzheimer's Disease, Chemistry - A European Journal (2017). DOI: 10.1002/chem.201703846

Related Stories

Discovery lights path for Alzheimer's research

October 19, 2017

A probe invented at Rice University that lights up when it binds to a misfolded amyloid beta peptide—the kind suspected of causing Alzheimer's disease—has identified a specific binding site on the protein that could facilitate ...

Alzheimer protein's structure may explain its toxicity

May 7, 2015

Researchers at the University of Illinois at Chicago have determined the molecular structure of one of the proteins in the fine fibers of the brain plaques that are a hallmark of Alzheimer's disease. This molecule, called ...

Recommended for you

Scientists discover new 'architecture' in corn

January 21, 2019

New research on the U.S.'s most economically important agricultural plant—corn—has revealed a different internal structure of the plant than previously thought, which can help optimize how corn is converted into ethanol.

Artificially produced cells communicate with each other

January 18, 2019

Friedrich Simmel and Aurore Dupin, researchers at the Technical University of Munich (TUM), have for the first time created artificial cell assemblies that can communicate with each other. The cells, separated by fatty membranes, ...

Using bacteria to create a water filter that kills bacteria

January 18, 2019

More than one in 10 people in the world lack basic drinking water access, and by 2025, half of the world's population will be living in water-stressed areas, which is why access to clean water is one of the National Academy ...

Hand-knitted molecules

January 18, 2019

Molecules are usually formed in reaction vessels or laboratory flasks. An Empa research team has now succeeded in producing molecules between two microscopically small, movable gold tips – in a sense as a "hand-knitted" ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.